Ignite Creation Date:
2024-05-05 @ 11:15 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01288092
Status:
WITHDRAWN
Last Update Posted:
2012-06-07
First Post:
2011-01-19
Brief Title:
BEZ235 Trial in Patients With HER2-Human Epidermal Growth Factor Receptor 2 Negative HR Hormonal Receptor Positive Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis